Insulin resistance and cancer: epidemiological evidence. Endocr Relat Cancer 19(5):F1-F8

Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan.
Cancer Science (Impact Factor: 3.52). 02/2010; 101(5):1073-9. DOI: 10.1111/j.1349-7006.2010.01521.x
Source: PubMed


Over the last 60 years, Japanese people have experienced a rapid and drastic change in lifestyle, including diet. Suspicions have been raised that so-called ‘Westernization’, characterized by a high-calorie diet and physical inactivity, is associated with increasing trends in the incidence of cancer of the colon, liver, pancreas, prostate, and breast, as well as type 2 diabetes. Epidemiological evidence from our prospective study, the Japan Public Health Center-based Prospective (JPHC) study, and systematic literature reviews generally support the idea that factors related to diabetes or insulin resistance are associated with an increased risk of colon (mostly in men), liver, and pancreatic cancers. These cancers are inversely associated with physical activity and coffee consumption, which are known to decrease the risk of type 2 diabetes. The suggested mechanism of these effects is that insulin resistance and the resulting chronic hyperinsulinemia and increase in bioavailable insulin-like growth factor 1 (IGF1) stimulate tumor growth. In contrast, associations with diabetes are less clear for cancer of the colon in women, and breast and prostate, which are known to be related to sex hormones. The effect of insulin resistance or body fat on sex-hormone production and bioavailability may modify their carcinogenic effect differently from cancers of the colon in men, and liver and pancreas. In conclusion, there is substantial evidence to show that cancers of the colon, liver, and pancreas are associated with insulin resistance, and that these cancers can be prevented by increasing physical activity, and possibly coffee consumption.
(Cancer Sci 2010; 101: 1073–1079)

Full-text preview

Available from:
  • Source
    • "Recent reviews and meta-analyses showed a strong positive association for DM and pancreatic cancer, hepatocellular carcinoma and endometrial cancer. DM also probably increases the risk for biliary tract, bladder, colorectal, oesophageal and breast cancers (Inoue and Tsugane, 2012). "

    Full-text · Dataset · Jan 2016
  • Source
    • "Recent reviews and meta-analyses showed a strong positive association for DM and pancreatic cancer, hepatocellular carcinoma and endometrial cancer. DM also probably increases the risk for biliary tract, bladder, colorectal, oesophageal and breast cancers (Inoue and Tsugane, 2012). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Metformin is known as a hypoglycaemic agent that regulates glucose homeostasis by inhibiting liver glucose production and increasing muscle glucose uptake. Colorectal cancer (CRC) is one of the most common cancers worldwide, with about a million new cases diagnosed each year. The risk factors for CRC include advanced age, smoking, black race, obesity, low fibre diet, insulin resistance, and the metabolic syndrome. We have searched Medline for the metabolic syndrome and its relation to CRC, and metformin as a potential treatment of colorectal cancer. Administration of metformin alone or in combination with chemotherapy has been shown to suppress CRC. The mechanism that explains how insulin resistance is associated with CRC is complex and not fully understood. In this review we have summarised studies which showed an association with the metabolic syndrome as well as studies which tackled metformin as a potential treatment of CRC. In addition, we have also provided a summary of how metformin at the cellular level can induce changes that suppress the activity of cancer cells.
    Full-text · Article · Jan 2016 · Asian Pacific journal of cancer prevention: APJCP
  • Source
    • "All environmental factors potentially involved in the occurrence of obesity, T2DM, insulin resistance Fetal malnutrition during pregnancy [46] [57] EDCs [76,80–85,87–89] Prenatal exposure to air pollution [26] [27] [28] T2DM [4] Insulin resistance [14] [16] [15] Acute pancreatitis Obesity [17] [110] Alcohol, current tobacco use [8] Hypertryglyceridemia [185] Organophosphorus pesticides [187] [188] [189] [190] [191] Hypercalcemia [186] Anticholinesterase insecticides [192] [193] Gallstones, biliary sludge [99] [7] Glyphosate [194] Organic solvents, pentachlorophenol [18] [195] Chronic pancreatitis Obesity [196] [21] Alcohol, current tobacco use [8] Celiac diasease [197] Occupational chemicals [19] [20] [21] Nutritional factors and rare metabolic factors [198] Pancreatic cancer Obesity [8,111–114,119,121,123,124] Current tobacco use [8] Chronic pancreatitis [199] Alcohol [8] Diabetes [200] Residence close to metal industries [24] Inherited familial disorders [201] [202] POPs [157] [158] [159] [160] [161] Long-life duration of obesity [119] Arsenic [167] [168] [169] [170] Insulin resistance [125] [126] Cadmium [171,169,172–175,123] Insulin-like growth factors and adipokines [127] [128] Lead [169] Fatty pancreas [135] Pancreatic islet/β-cell damage and dysfunction Nutritional conditions [203] Particulates of less than 10 μm (PM10) Maternally derived gut microbiota [204] Nitrogen oxides, non-methane organic volatile compounds (VOCs) [22] Variations of intestinal microbiota [205] [206] Bisphenol-A, phthalate [76] [77] [78] [79] Ozone and sulfate [207] Nitrates, nitrites, N-nitroso compounds, persistent organochlorine pollutants [208] [209] Chromium [210] Lead [211] EDCs, endocrine disrupting chemicals; POPs, persistent organic pollutants; T2DM, type 2 diabetes mellitus. rat F1 female offspring. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The worldwide obesity epidemic is paralleled by a rise in the incidence of pancreatic disorders ranging from "fatty" pancreas to pancreatitis and cancer. Body fat accumulation and pancreatic dysfunctions have common pathways, mainly acting through insulin resistance and low-grade inflammation, frequently mediated by the epigenome. These mechanisms are affected by lifestyle and by the toxic effects of fat and pollutants. An early origin is common, starting in pediatric age or during the fetal life in response to nutritional factors, endocrine disruptor chemicals (EDCs) or parental exposure to toxics. A "fatty pancreas" is frequent in obese and is able to induce pancreatic damage. The fat is a target of EDCs and of the cytotoxic/mutagenic effects of heavy metals, and is the site of bioaccumulation of lipophilic and persistent pollutants related with insulin resistance and able to promote pancreatic cancer. Increased Body Mass Index (BMI) can act as independent risk factor for a more severe course of acute pancreatitis and obesity is also a well-known risk factor for pancreatic cancer, that is related with BMI, insulin resistance, and duration of exposure to the toxic effects of fat and/or of environmental pollutants. All these mechanisms involve gene-environment interactions through epigenetic factors, and might be manipulated by primary prevention measures. Further studies are needed, pointing to better assess the interplays of modifiable factors on both obesity and pancreatic diseases, and to verify the efficacy of primary prevention strategies involving lifestyle and environmental exposure to toxics
    Full-text · Article · Dec 2014 · European Journal of Internal Medicine
Show more